From drawings of rainbows displayed in windows to a weekly round of applause, the NHS has rightly received much admiration this year. Its inspirational front line fight against coronavirus has shown just how valuable this venerated institution is.
And our clients are bringing their investment backing and expertise to some of the innovative med-tech businesses that support it through the Coutts Investment Club.
The club introduces financially sophisticated, high net worth clients interested in investing to exciting new private companies.
Hans Prottey, who heads the club, explains: “Our members are a select group of highly experienced and financially sophisticated investors – successful entrepreneurs, C-suite executives, private equity professionals, hedge fund managers and family offices. We introduce them to a carefully selected set of fast-growing companies with a clear competitive advantage and strong management teams.
“Although often higher risk, it can be extremely rewarding – professionally and financially – for our clients, giving them an endeavour that meets their needs by going further than standard investing.”
The club covers a wide range of sectors but, in our very own celebration of the NHS, here we feature four Coutts Investment Club companies that support the much-loved service.
Please note: Our profile of these companies does not constitute a personal recommendation and if you’d like to know more, you should speak to your private banker for further context.
1) Testing for Covid-19 - QuantuMDx
How they help: QuantuMDx has developed molecular diagnostic technology which detects a range of infectious diseases and drug susceptibility among patients. Portable, affordable and easy to use, their device can be used in a wide range of settings, enabling diagnosis within 30 minutes. It will launch with a test for coronavirus, developed in response to the COVID-19 pandemic, and another for flu ahead of the upcoming flu season.
In their own words: “At the beginning of the pandemic I caught COVID-19. It was obvious to me, as a geneticist with a passion for epidemiology, that a pandemic was about to emerge. It’s a privilege for us to use our expertise to develop a test that can be used in laboratories and on our own device, contributing to the national and international efforts to tackle this disease.”
Jonathan O’Halloran, CEO
More info: quantumdx.com
2) Helping treat cancer – Combat Medical
How they help: Combat has developed a way to deliver cancer treatment that reduces the side effects involved and the chance of the disease recurring. Their technology makes administering the required drugs more effective, and improves the treatment of a range of cancers, including three of the most common.
In their own words: “Cancer treatments globally have reduced significantly due to COVID-19. In the UK we have seen a reduction in surgery by around 60% and chemotherapy treatments by around 75%. This has to be addressed or the UK will suffer one of the highest excess death rates in Europe. Combat stands ready to continue supporting the NHS in any way to ensure cancer patients receive treatments.”
Edward Bruce-White, CEO
More info: combat-medical.com